Cargando…

Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice

PMX53 and PMX205 are cyclic hexapeptide inhibitors of complement C5a receptors (C5aR1), that are widely used to study C5aR1 pathobiology in mouse models of disease. Despite their widespread use, limited information regarding their pharmacokinetics have been reported. Here, a bioanalytical method for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Vinod, Lee, John D., Clark, Richard J., Woodruff, Trent M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970165/ https://www.ncbi.nlm.nih.gov/pubmed/29802264 http://dx.doi.org/10.1038/s41598-018-26387-4

Ejemplares similares

Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice
por: Kumar, Vinod, et al.
Publicado: (2020)

Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking
por: Tamamis, Phanourios, et al.
Publicado: (2014)

Is it true that PMX-DHP can improve lung oxygenation?
por: Ikeda, T, et al.
Publicado: (2003)

Effect of PMX-DHP according to differences in infection site
por: Ikeda, T, et al.
Publicado: (2001)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

pmx: Automated protein structure and topology generation for alchemical perturbations
por: Gapsys, Vytautas, et al.
Publicado: (2015)

ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms
por: Iacobaş, Dumitru A., et al.
Publicado: (2018)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
por: Shinomiya, Shohei, et al.
Publicado: (2021)

A retrospective investigation of the pmx-dhp's efficacy in 88 severe sepsis cases
por: Tanaka, M, et al.
Publicado: (2015)

Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections
por: Ikeda, T, et al.
Publicado: (2000)

Antitumor Quinol PMX464 Is a Cytocidal Anti-trypanosomal Inhibitor Targeting Trypanothione Metabolism
por: König, Janine, et al.
Publicado: (2011)

PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series
por: Kuwana, Tsukasa, et al.
Publicado: (2021)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Quantum Mechanical Calculation of Noncovalent Interactions: A Large-Scale Evaluation of PMx, DFT, and SAPT Approaches
por: Li, Amanda, et al.
Publicado: (2014)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
por: Golovine, Konstantin, et al.
Publicado: (2023)

Pan-peritonitis due to intestinal perforation, and efficacy of direct hemoperfusion with polymyxin B immobilized fiber (PMX-20R)
por: Ikeda, T
Publicado: (1999)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Largazole Pharmacokinetics in Rats by LC-MS/MS
por: Yu, Mingming, et al.
Publicado: (2014)

First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review
por: Fu, Weijia, et al.
Publicado: (2021)

Development and validation of a LC–MS/MS method for quantification of hetrombopag for pharmacokinetics study
por: Chen, Tao, et al.
Publicado: (2015)

The Characteristics of Patients with Severe COVID-19 Pneumonia Treated with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber Column (PMX-DHP)
por: Kuwana, Tsukasa, et al.
Publicado: (2022)

LC-MS/MS Validation Analysis of Trastuzumab Using dSIL Approach for Evaluating Pharmacokinetics
por: Budhraja, Rohit H., et al.
Publicado: (2016)

Optimization of the CYP inhibition assay using LC-MS/MS
por: Abduraman, Muhammad Asyraf, et al.
Publicado: (2022)

Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC–MS/MS
por: Zhang, Chengyin, et al.
Publicado: (2018)

Determination and pharmacokinetics study of oxyclozanide suspension in cattle by LC-MS/MS
por: Zhang, Jili, et al.
Publicado: (2019)

A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid
por: Sidhu, Rohini, et al.
Publicado: (2015)

Development and validation of a novel LC-MS/MS assay for C-peptide in human serum
por: Owusu, Benjamin Y., et al.
Publicado: (2020)

Pharmacokinetic analysis and tissue distribution of Vam3 in the rat by a validated LC-MS/MS method
por: Zhang, Ruixia, et al.
Publicado: (2015)

Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC–MS/MS Method
por: Li, Chi-Lin, et al.
Publicado: (2018)

Validated LC-MS/MS Method for the Determination of Scopoletin in Rat Plasma and Its Application to Pharmacokinetic Studies
por: Zeng, Yingchun, et al.
Publicado: (2015)

PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
por: Callister, M E, et al.
Publicado: (2008)

LC-ESI-MS/MS Analysis and Pharmacokinetics of GP205, an Innovative Potent Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease in Rats
por: Yang, Nan, et al.
Publicado: (2015)

LC–MS/MS assay for the determination of natamycin in rabbit and human plasma: Application to a pharmacokinetics and protein binding study
por: Chhonker, Yashpal Singh, et al.
Publicado: (2013)

Pharmacokinetic Comparisons of Naringenin and Naringenin-Nicotinamide Cocrystal in Rats by LC-MS/MS
por: Xu, Dan, et al.
Publicado: (2020)

Determination and pharmacokinetics study of UK-5099 in mouse plasma by LC–MS/MS
por: Zeng, Qingyuan, et al.
Publicado: (2022)

Development of an LC–MS/MS Assay and Toxicokinetic Characterization of Hexamethylenetetramine in Rats
por: Kim, Woojin, et al.
Publicado: (2023)

The Pharmacokinetics in Mice and Cell Uptake of Thymus Immunosuppressive Pentapeptide Using LC-MS/MS Analysis
por: Chen, Shang, et al.
Publicado: (2022)

Optimization, validation and application of an assay for the activity of HMG-CoA reductase in vitro by LC–MS/MS()
por: Wang, Jing, et al.
Publicado: (2015)

Preclinical Pharmacokinetics of Scoparone, Geniposide and Rhein in an Herbal Medicine Using a Validated LC-MS/MS Method
por: Hsueh, Tun-Pin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pq8tfbad4h4j9i82d86hnmttip